FindTrial
Sign In

An observational study to measure blood levels of vitamin B12 in patients taking antidiabetic medication metformin

â??SERUM VITAMIN B12 LEVELS IN METFORMIN TREATED TYPE 2 DIABETIC PATIENTS : A CROSS SECTIONAL STUDYâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/012955
Enrollment
82
Registered
2018-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type 2 Diabetes Mellitus

Interventions

None listed

Sponsors

Arundhati Salunke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male and female patients. 2.Atleast 18 years of age diagnosed with 3.ype 2 Diabetes Mellitus and receiving metformin for more than one year were included in the study

Exclusion criteria

Exclusion criteria: 1.Patients with type 1 diabetes mellitus, 2.pregnant patients 3.patients suffering from liver, kidney, thyroid disorders, 4.HIV positive 5.alcoholics 6.those with history suggestive of malabsorption (irritable bowel disease, gastrectomy, ileal resection) 7.patients declining to participate were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Serum Vitamin B12 levelsTimepoint: One Year—

Secondary

MeasureTime frame
Risk factors associated with Vitamin B12 deficiency (age, gender, dose and duration of metformin use, duration of Type 2 diabetes Mellitus, vegan status, HbA1c levels, use of H2 antihistaminics, Use of sulfonylurea, Use of multivitamin)Timepoint: One Year—

Countries

India

Contacts

Public ContactArundhati Salunke

Government Medical College, Miraj

shraddha.pore7@gmail.com9371126946

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026